Showing results (41-50 of 861) with videos related to
Sort By:
Pageof 87
Med (New York, N.Y.)|November 6, 2024
Arab founder variants: Contributions to clinical genomics and precision medicineLama AlAbdi, Sateesh Maddirevula, Bayan Aljamal, et al.Med (New York, N.Y.)|February 28, 2025
A progranulin variant causing childhood interstitial lung disease responsive to anti-TNF-α biologic therapyJohn C Kennedy, Sara O Vargas, Martha P Fishman, et al.Med (New York, N.Y.)|March 5, 2025
Results from the phase 2/3 DAFFODIL study of trofinetide in girls aged 2-4 years with Rett syndromeAlan K Percy, Robin Ryther, Eric D Marsh, et al.Med (New York, N.Y.)|August 10, 2024
Opportunities and challenges for immunosuppression in the context of pig-to-human xenotransplantationGuillaume Onyeaghala, Casey R Dorr, Ajay K IsraniMed (New York, N.Y.)|August 9, 2024
Preoperative camrelizumab combined with chemotherapy for borderline resectable ESCC: A single-arm, prospective, phase 2 studyGuoqing Zhang, Teng Mu, Yan Zhang, et al.Med (New York, N.Y.)|August 10, 2024
Checkmate 77T: Perioperative chemoimmunotherapy outperforms in early-stage NSCLCDanielle Brazel, Misako NagasakaMed (New York, N.Y.)|August 10, 2024
Storage, preservation, and rehabilitation of living heart valves to treat congenital heart diseaseElizabeth M Cordoves, Giovanni Ferrari, Emmanuel Zorn, et al.Med (New York, N.Y.)|August 16, 2024
Homoharringtonine synergizes with venetoclax in early T cell progenitor acute lymphoblastic leukemia: Bench and bedShanshan Suo, Shu Sun, Le Xuan Truong Nguyen, et al.Med (New York, N.Y.)|January 24, 2023
Immune signatures predict development of autoimmune toxicity in patients with cancer treated with immune checkpoint inhibitorsNicolas Gonzalo Nuñez, Fiamma Berner, Ekaterina Friebel, et al.Med (New York, N.Y.)|December 13, 2022
Clinically oriented prediction of patient response to targeted and immunotherapies from the tumor transcriptomeGal Dinstag, Eldad D Shulman, Efrat Elis, et al.Pageof 87